Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human STK10 Stable Cell Line

    [CAT#: S01YF-1123-KX284]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1192 Magic™ Human LOK(STK10) in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    STK10
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    HeLa; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Reproductive Research; Cancer Research
    Related Diseases
    Testicular Germ Cell Tumor and Germ Cell Tumor. Among its related pathways are Signaling by Rho GTPases and RHOC GTPase cycle
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The human STK10 gene encodes the enzyme serine/threonine-protein kinase 10. This gene is similar to numerous known polo-like kinases and encodes a member of the Ste20 family of serine/threonine protein kinases. The protein can phosphorylate and interact with polo-like kinase 1, and normal cell cycle progression is disrupted when a kinase-dead variant of the protein is overexpressed. By using the mitogen-activated protein kinase kinase 1 pathway, the kinase can also adversely control the production of interleukin 2 in T-cells. The customized STK10 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Kevin

    Using the STK10 KO cell line from Creative Biolabs has been a game-changer for our research. Jun 07 2020

    chat Verified Customer

    chat Lisa

    It was instrumental in our study, allowing us to specifically target STK10 proteins and investigate their role in disease. Sep 18 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Generation and validation of STK10 knockout cervical cell lines.

    In order to transfect HeLa and Caski cells, the guide-RNA oligonucleotides were created, synthesized, and cloned into a pX459 vector. By sequencing the target DNA PCR products, the indel mutations in these cell lines were verified.

    Ref: Zhang, Lu, et al. "Knockout of STK10 promotes the migration and invasion of cervical cancer cells." Translational Cancer Research 9.11 (2020): 7079.

    Pubmed: 35117313

    DOI: 10.21037/tcr-20-1601

    Research Highlights

    This is the first study to show that STK10 not only phosphorylates ERM proteins but also carries out a number of physiological tasks and is essential for the migration and invasion of cervical cancer cells.
    Zhang, Lu, et al. "Knockout of STK10 promotes the migration and invasion of cervical cancer cells." Translational Cancer Research 9.11 (2020): 7079.
    Pubmed: 35117313   DOI: 10.21037/tcr-20-1601

    This is the first study to show that STK10 is critical for PCa cell migration and proliferation, which will be helpful for future research into the etiology of the illness.
    Zhang, Lu, et al. "STK10 knockout inhibits cell migration and promotes cell proliferation via modulating the activity of ERM and p38 MAPK in prostate cancer cells." Experimental and Therapeutic Medicine 22.2 (2021): 1-8.
    Pubmed: 34149897   DOI: 10.3892/etm.2021.10283

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare